Senate must act on bill to advance research
In response to the July 15 News editorial, “Bipartisan legislation will provide an overdue boost for medical innovation,” House passage of the 21st Century Cures Act is a significant development for patients and researchers alike as many members of Congress demonstrate their determination to support research and medical innovation.
The Senate must now pick up the mantle and craft similar legislation to ensure the promise of a more efficient and speedier process for the discovery, development and delivery of new therapies. The additional funds for the National Institutes of Health and the Food and Drug Administration included in the House bill are essential to keeping pace with scientific opportunity and the approval of new drugs and devices.
A plurality of Americans agree that government spending for biomedical and health research is not currently enough, according to public opinion polls commissioned by Research!America. Patients, researchers and all who value medical progress should urge New York Sens. Kirsten Gillibrand and Charles Schumer to help advance the bill this year while the momentum is with us.
President and CEO